The FDA had listed substances like BPC-157 in 503A Category 2 (bulk substances that may present significant safety risks for compounding), and while BPC-157 moved into the nominated-but-withdrawn table in April 2026, it is still not on the 503A Bulks List
Cardiovascular Risk Reduction: Helps lower the risk of major heart-related issues, such as stroke or heart attack, in adults who have both heart disease and obesity/overweight
This publication has not received compensated product samples for testing, has not interviewed brand personnel, has not been granted access to internal product specifications beyond what is publicly published, has not conducted laboratory or clinical performance testing, and has not independently audited current licensing, fulfillment, pharmacy operations, or quality practices of the listed pharmacy providers
Theyre especially appealing for women seeking uterine preservation, either for fertility or personal preference, and for those wishing to avoid the risks associated with extensive surgery